Riverbridge Partners LLC reduced its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,448,855 shares of the company's stock after selling 43,614 shares during the quarter. Riverbridge Partners LLC owned 0.88% of Option Care Health worth $50,637,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of the business. Blue Trust Inc. lifted its position in shares of Option Care Health by 95.4% during the 1st quarter. Blue Trust Inc. now owns 5,282 shares of the company's stock worth $185,000 after buying an additional 2,579 shares during the last quarter. Janney Capital Management LLC bought a new stake in shares of Option Care Health during the 1st quarter worth $369,000. Johnson Investment Counsel Inc. lifted its position in shares of Option Care Health by 3.7% during the 1st quarter. Johnson Investment Counsel Inc. now owns 87,691 shares of the company's stock worth $3,065,000 after buying an additional 3,120 shares during the last quarter. State of Alaska Department of Revenue lifted its position in shares of Option Care Health by 2.7% during the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock worth $696,000 after buying an additional 525 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in shares of Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock worth $289,000 after buying an additional 1,691 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on OPCH shares. JPMorgan Chase & Co. upped their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Wednesday, June 18th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $35.50.
View Our Latest Report on OPCH
Option Care Health Trading Down 1.5%
Shares of OPCH stock traded down $0.48 on Monday, hitting $31.05. The company had a trading volume of 1,865,840 shares, compared to its average volume of 1,879,989. The firm has a market cap of $5.08 billion, a P/E ratio of 25.04, a P/E/G ratio of 1.90 and a beta of 0.74. The stock's 50-day moving average is $32.06 and its two-hundred day moving average is $30.69. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.02 and a current ratio of 1.54. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.
Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business's quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.26 earnings per share. On average, equities research analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
